Anixa Biosciences (ANIX) Current Deferred Revenue (2011 - 2014)
Anixa Biosciences' Current Deferred Revenue was $1.19 million in fiscal Q2 2014 (quarter ended Apr 30, 2014), unchanged from $1.19 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Current Deferred Revenue (2011 - 2014) Analysis & Trends
From fiscal Q3 2011 onward, Anixa Biosciences has reported Current Deferred Revenue for 12 quarters.
- In earlier fiscal years, Current Deferred Revenue was $1.19 million in FY2012 (-27.8%) and $1.64 million in FY2011.
- Quarterly Current Deferred Revenue has moved between $1.19 million (fiscal Q3 2012) and $2.57 million (fiscal Q3 2011) over five years.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 0.0% (fiscal Q2 2014) to 53.9% (fiscal Q3 2012).
- Per Business Quant data, ANIX's Current Deferred Revenue in the three fiscal quarters before Q2 2014 was $1.19 million (Q1 2014), $1.19 million (Q4 2013) and $1.19 million (Q3 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2014 | 1.19 Mn |
| Jan 31, 2014 | 1.19 Mn |
| Oct 31, 2013 | 1.19 Mn |
| Jul 31, 2013 | 1.19 Mn |
| Apr 30, 2013 | 1.19 Mn |
| Jan 31, 2013 | 1.19 Mn |
| Oct 31, 2012 | 1.19 Mn |
| Jul 31, 2012 | 1.19 Mn |
| Apr 30, 2012 | 1.43 Mn |
| Jan 31, 2012 | 1.44 Mn |
| Oct 31, 2011 | 1.64 Mn |
| Jul 31, 2011 | 2.57 Mn |
API Access
Anixa Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();